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Abstract   
Background: Egg allergy is a leading cause of food allergy in young infants, however little 
is known about early allergen specific T cell responses which predate the presentation of egg 
allergy, and if these are altered by early egg exposure.  
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patterns of egg exposure and subsequent IgE-mediated egg allergy. 
Methods: Egg-specific T cell cytokine responses (IL-5, IL-13, IL-10, IFNγ and TNFα)  to 
ovomucoid (OM), ovalbumin (OVA), conalbumin (CON) and lysozyme (LYS) were 
measured in infants with eczema at 4 months of age (n=40), before randomisation to receive 
‘early egg’ or a placebo as part of a randomised controlled trial (Australian New Zealand 
Clinical Trials Registry number 12609000415202), and at 12 months of age (n=58), when 
IgE-mediated egg allergy was assessed by skin prick test and food challenge.  
Results:  In 4 month old infants, who had not directly ingested egg, those who  subsequently 
developed egg allergy already had significantly higher Th2 cytokine responses to multiple 
egg allergens, particularly elevated IL-13 responses to OVA (P=0.004), OM (P=0.012) and 
LYS (P=0.003), and elevated IL-5 to the same antigens (P=0.031, 0.04 and 0.003 
respectively). IL-13 responses (to OVA and LYS) and IL-5 responses (to LYS) at 4 months 
significantly predicted egg allergy at 12 months. All responses significantly declined with age 
in the egg allergic infants, and this did not appear to be modified by ‘early’ introduction of 
egg.  
Conclusions & Clinical Relevance: Elevated egg-specific Th2 cytokine responses were 
established prior to egg ingestion at 4 months and were not significantly altered by 
introduction of egg. Th2 responses at 4 months of age predicted egg allergy at 12 months, 
suggesting that this could be used as a biomarker to select infants for early prevention and 
management strategies.  
 
Introduction 
Hen’s egg is one of the most common food allergens to induce T helper 2 (Th2) allergic 
immune responses in young infants[1-3]. IgE-mediated allergic reactions can occur early in 
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that as many as one third of infants with eczema may have evidence of sensitisation and IgE-
mediated symptoms on ingestion of egg at 4 months of age[4]. This suggests much earlier 
dysregulation of allergen-specific T-cell responses, and that these may be established and 
consolidated even before 4 months of age in some children, particularly children with 
eczema. In addition to genetic predisposition, this increase risk has been attributed to 
increased sensitisation risk through impaired cutaneous barrier function[7]. However, this is 
highly variable and not all infants with severe eczema develop egg or other food allergies. 
Given the risk of reactivity in this group, there is a recognised need to further characterise the 
preceeding immunological events leading to egg sensitisation, as this may help define 
pathways to sensitisation, facilitate early identification of children likely to react, and direct 
potential strategies for preventive interventions in the future.  
 
As an important prelude, this study investigated the egg allergen specific T-cell responses in 
this high risk group of children, with moderate to severe eczema, prior to their presentation 
with egg allergy.  While most previous studies of egg-sensitised patients have focused on 
responses to ovalbmumin (OVA) as the most abundant protein in hen’s egg[8-10], this study 
provided the opportunity to examine  early responses to a broader range of hen’s egg proteins 
including ovomucoid (OM, Gal d 1), ovalbumin (OVA, Gal d 2), conalbumin (CON, Gal d 
3), and lysozyme (LYS, Gal d 4),  which are also capable of inducing the production of 
specific-IgE[11].  
 
For the first time we investigated how early patterns of T cell responsiveness to this wider 
range of hen’s egg allergens at four months of age predicted subsequent IgE-mediated egg 
allergy. Additionally we determined whether earlier introduction of egg in solid foods 
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Materials and methods 
Subjects  
The study population comprised a subset of infants who participated in a randomized 
controlled trial (RCT) investigating the effects of early, regular egg consumption on the 
development of IgE-mediated egg allergy (Australian New Zealand Clinical Trials Registry 
number 12609000415202).  This study was approved by the Princess Margaret Hospital 
Human Research Ethics Committee (approval number 1635/EP), and written parental consent 
was obtained from all the participants. Full details of the RCT have been previously 
published[4]. Briefly, infants with moderate to severe eczema determined using a 
standardized Scoring Atopic Dermatitis (SCORAD)[12] score of ≥ 15 and no known 
ingestion of egg in solid foods were recruited at 4 months of age. The infants were 
randomized to receive either one teaspoon of pasteurized raw whole egg powder 
(intervention group) or rice powder (control group) daily from 4 to 8 months of age.  At 8 
months of age, cooked egg was introduced to both the intervention and control group infants 
after a medically observed introduction of hard-boiled egg.  The primary outcome was IgE-
mediated egg allergy at 12 months of age defined by a medically observed allergic reaction to 
a pasteurized raw egg challenge and a positive skin prick test to egg[4]. The subset of RCT 
participants included in this study was determined by availability of sufficient blood volume 
collected for cell culture analysis.  
 
Blood collection and processing 
Blood samples were collected at 4 months of age prior to any ingestion of the study powder, 
and again at 12 months of age on the day of a skin prick test and egg challenge.  Peripheral 
blood was collected by venipuncture into lithium-heparinized tubes and processed within 4 
hours. Heparinized whole blood was pelleted by centrifugation, and plasma was collected and 
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centrifugation (Lymphoprep™) method. Peripheral blood mononuclear cells (PBMC’s) were 
isolated, washed using Roswell Park Memorial Institute (RPMI) media (Gibco Life 
Technology, Grand Island, NY, USA) and stored in RPMI (49%), heat-inactivated fetal calf 
serum (43.5%) and dimethylsulphate (7.5%). Cells were stored in 1 ml aliquots at a 
concentration of no more than 15 x 106 cells/ml, transferred to a CoolCell® and immediately 
stored at -80℃ for a standardized controlled-rate of -1℃/minute cell freezing. Within 24 
hours of freezing, PBMC’s were transferred to liquid nitrogen for long-term storage. 
 
Mononuclear cell culture 
PBMC cell culture was conducted using the methods as per detailed previously [13,14]. 
Briefly, cryopreserved mononuclear cells were thawed and transferred to RPMI culture 
media. Cells were counted, viability tested using try-pan blue (Gibco Life Technology, Grand 
Island, NY, USA) and transferred to AIM V (Gibco Life Technology) tissue culture media 
with 2-mercaptoethanol (ME) (Sigma-Aldrich Co, NSW Australia) at a concentration of 2 x 
106 cells/ml. Hen’s egg allergens: a) ovalbumin (OVA 100μg/ml), b) ovomucoid (OVM 
1mg/ml), c) conalbumin (CON 200μg/ml) and d) lysozyme (LYS 500μg/ml), all purchased 
from Sigma-Aldrich Co, NSW Australia. These concentrations were identified as optimal for 
in vitro T cell stimulation in preliminary titration experiments. As OVA is routinely used to 
stimulate PBMC’s at a concentration of 100ug/ml, this was used as the starting concentration 
for the other egg allergens. The concentration was deemed optimal when responses were 
consistent in known egg-allergic infants, whilst maintaining minimal responses in unaffected 
infants. A mitogen phytohaemagglutinin (PHA) was used as a positive control, to ensure that 
PBMC’s were responding suitably to stimulation. Non-stimulated negative controls were also 
included for each infant. Lymphocytes were cultured for 48 hours in 5% CO2 incubators at 
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number of stimulations varied between individuals, and was determined by the number of 
available mononuclear cells. 
 
Cytokine measurements – Luminex Xmap multiplex 
Cytokines in once-thawed lymphocyte culture supernatants were quantified using Luminex 
Xmap multiplex technology (Luminex Corp, Austin, TX, USA) using an in-house method 
previously described[8]. Primary and secondary antibodies for cytokines IL-5, IL-10, IL-13, 
IFNγ and TNFα were purchased from BD Biosciences (North Ryde, Australia). Standards for 
IL-5, IL-10 and IFNγ were purchased from BD Bioscience, and IL-13 and TNFα standards 
were purchased from R&D Systems (Minneapolis, USA). Quality controls were run on each 
plate. The lower detection limit of the assay was 3 pg/ml and the upper limit varied between 
10000-30000 pg/ml. Samples that were below detection limit were assigned the value of the 
lowest detection (3 pg/ml). The cytokine levels were shown as the difference between the 
stimulated cells and control cells, which were not stimulated.  
 
Clinical outcomes and allergy assessments 
Throughout this study, an allergic reaction was defined as at least 3 concurrent non-contact 
urticaria persisting for at least 5 minutes and/or generalized skin erythema, and/or vomiting, 
and/or anaphylaxis within 2 hours of allergen exposure[4]. All infants (including those that 
reacted to the study powder at 4 months of age) underwent an allergy assessment at 12 
months of age, including a SCORAD assessment, skin prick testing, blood sample collection 
and egg challenge[4]. The presence of IgE-mediated egg allergy at 12 months of age was 
defined as a positive allergic reaction during a medically supervised raw egg challenge and 
evidence of sensitization (positive skin prick test) to egg, or medical advice not to proceed 
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Statistical analysis 
Differences in means for parametric data were compared using T-tests. Non-parametric data 
were analyzed between groups using Mann-Whitney U-tests. Chi square tests were used for 
comparisons of categorical data between groups. Where possible non-parametric data were 
log transformed to achieve a normal distribution for the remaining statistics. Binary logistic 
regression was used to calculate prediction of allergic outcomes. Paired t-tests were used to 
quantify changes over time. All statistics were performed using SPSS v20 (IBM), and figures 





This study included 68 infants from the clinical trial who had blood samples available for 
cytokine analysis, as illustrated in Figure 1. The baseline characteristics of this subset, shown 
in Table 1, are representative of the total 86 participants in the RCT. Cytokine responses were 
measured in 40 infants at 4 months of age (n=22 ‘early egg’ intervention group, n= 18 
‘delayed egg’ rice control group) and 58 infants at 12 months of age (n=33 ‘early egg’ 
intervention group, n=25 ‘delayed egg’ rice control group). For 30 infants (n=15 ‘early egg’ 
group, n=15 ‘delayed egg’ group) cytokine data was available at both time points. We 
compared T cell responses in infants according to egg reactivity (at both 4 and 12 months) 
and according to the study intervention. 
 
Baseline cytokine responses at 4 months of age, and comparison of responses in 4-month 
old egg-reactors and non-reactors. 
Prior to the intervention, there were no differences in cytokine responses for IL-5 or IL-13 
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the egg allergens: OVA, OM, CON or LYS at 4 months of age (Table 2). There were also no 
differences between the groups for IL-10, IFNγ or TNFα responses as summarized in 
supplementary table 1 available in the online repository.  
 
A total of 15/49 (31%) infants in the ‘early egg’ intervention group had a confirmed allergic 
reaction to the pasteurized raw egg powder at study enrolment. Cytokine response data was 
available for 5 infants who reacted to the egg study powder and 17 infants who tolerated the 
egg powder. In those infants who reacted to the egg powder, egg-specific induced Th2 
cytokines were significantly higher: IL-13 (OVA, OM and LYS), and IL-5 (OVA and CON) 
than infants who tolerated the egg powder (Figure 2). There was also a significantly higher 
production of IFNγ to lysozyme in the egg powder reactors (p=0.011), than in the non-
reactors (data in supplementary table 2). There were no other differences in IFNγ, IL-10 or 
TNFα between infants who reacted and those who tolerated the egg powder at 4 months of 
age, data as summarized in supplementary table 2 available in the online repository. PHA 
stimulation was used to assess viability in all samples, and the level of cytokines produced 
did not differ significantly between groups, with age or phenotype (results not shown).  
 
Effect of the dietary intervention on cytokine responses at 12 months of age 
Egg-specific Th2 cytokines IL-5 and IL-13 responses at 12 months of age did not differ 
according to the intervention groups (as shown in Table 3).  No differences between the 
groups were also found for IL-10, IFNγ or TNFα responses, as summarized in supplementary 
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Relationship between early cytokine responses (at 4 months) and subsequent IgE-mediated 
egg allergy at 12 months of age 
A total of 35 infants (n=12 with IgE-mediated egg allergy) had cytokine responses measured 
at 4 months of age and egg allergy assessed at 12 months of age. Elevated IL-5 and IL-13 
responses to egg allergens (OVA, OM, LYS) at 4 months of age were associated with IgE-
mediated egg allergy at 12 months of age (Figure 3). There were no associations between IL-
10, TNFα and IFNγ responses with IgE-mediated egg allergy, data not shown.  
 
In 30 infants (n=11 with IgE-mediated egg allergy) with both 4 and 12 month cytokine data 
as well as clinical egg allergy status data at 12 months, IgE-mediated egg allergy was 
predicted by 4 month of age OVA IL-13 (β=1.1; 95%CI 1.09-8.7; P=0.034), LYS IL-13 (β
=1.2; 95%CI 1.2-9.3; P= 0.03) and LYS IL-5 (β=0.8; 95%CI 1.2-4.3; P=0.014). 
 
Changes in cytokine responses with age. 
In 30 infants (n=11 with IgE-mediated egg allergy) with cytokine data available at both time 
points, infants with IgE-mediated egg allergy at 12 months of age showed a striking decrease 
in induced Th2 cytokine responses between 4 and 12 months of age (Figure 4). Whilst all egg 
allergens followed the same pattern, IL-13 decreased significantly in response to stimulation 
with OM and LYS (P=0.007 and P=0.019 respectively) and IL-5 in response to LYS 
(P=0.012). Infants who tolerated egg at 12 months of age, did not show any significant 
decrease in IL-5 and IL-13 responses between 4 and 12 months (Figure 4).  
 
Relationship between IgE-mediated egg allergy and cytokine responses at 12 months At 12 
months of age, 58 infants had T cell responses measured (n=25 with IgE-mediated egg 
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cytokine responses to LYS (IL-5 (P=0.035), IL-13 (P=0.034)) were significantly higher in 
infants with IgE-mediated egg allergy (Figure 3). There were no significant differences for 
any other egg allergen for cytokines IL-5 and IL-13 (Figure 3). Again there were no 
differences for IL-10, IFNγ or TNFα for any of the egg allergens, data as summarized in 
supplementary table 4 available in the online repository. At 12 months of age, LYS IL-13 and 
IL-5 predicted egg allergy status at that time point (β=0.4; 95%CI 1.0-2.4; P= 0.039) and (
β=0.3; 95%CI 1.0-1.8; P= 0.05) respectively.  
 
Relationship between eczema (SCORAD) assessments and cytokine responses  
Eczema (SCORAD) assessments and cytokine data were available in 40 infants at 4 months 
and 58 infants at 12 months of age.  There was no association between IL-5 or IL-13 
responses to any of the egg proteins and eczema severity on the day of assessment for either 
time point. The data collected on topical steroid use was not sufficient to accurately assess in 
relation to cytokine production. 
 
Egg specific IgG4 levels and cytokine responses 
Egg-specific IgG4 levels were significantly higher in the infants who received the egg 
powder from 4 months of age[4]. However, production of cytokines, including egg-specific 
regulatory cytokine IL-10, was not correlated with the level of egg-specific IgG4 measured at 
12 months of age.  
 
Discussion 
This is the first study to report patterns of infant PBMC responses to a comprehensive array 
of egg proteins in relation to patterns of egg exposure and subsequent egg allergy. We have 
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high proportion of infants with eczema by 4 months of age, prior to the introduction of egg in 
solid foods. Moreover, IL-5 and IL-13 responses at this age predicted the development of 
challenge-proven egg allergy later in infancy.  
 
These findings clearly demonstrate that immunological events leading to egg sensitisation are 
commonly initiated prior to the introduction of egg in solid foods, particularly in this high-
risk phenotype.  This highlights the need to understand other potential mechanisms and 
routes of sensitisation, during lactation or even in utero. Egg proteins are known to cross the 
placenta[15], and have been detected in breast milk [16], providing potential avenues of 
exposure. Transcutaneous exposure also may be a particularly important route of exposure in 
children with moderate to severe eczema[7]. In addition to impaired skin barrier function, 
children with eczema also show evidence of increased gut mucosal permeability[17,18], 
which may provide an additional mechanism in dysregulation of mucosal responses and the 
development of food allergy. On the other hand, many children without eczema still develop 
food allergy, and it will be important to repeat these studies in egg allergic children without 
eczema.  
 
Another interesting finding in this study, was that the intervention with early regular oral 
exposure to egg from 4 months of age was not associated with any significant effects on egg-
specific IL-5, IL-10, IL-13, IFNγ or TNFα cytokine responses.  This could be because Th2 
cytokine production was already well established in many infants by 4 months of age prior 
to the intervention. It is also recognized that the development of oral tolerance is not 
necessarily associated with the reduction in allergen specific IgE or underlying Th2 
responses, as noted in studies of oral immunotherapy[19]. Other immunological parameters, 
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we have previously noted that this intervention was associated with significantly higher egg-
specific IgG4 levels at 12 months of age compared to the ‘delayed egg’ control group[4]. 
However, while this suggests that the early, regular introduction of egg did influence 
underlying tolerance-associated cellular mechanisms, we did not see any continuous effects 
on the production of cytokines such as IL-10 and IFNγ, which have been associated with 
tolerance in other studies[20]. Whilst egg allergic infants did produce significantly higher 
levels of IFNγ in response to lysozyme at four months of age, this was a stand-alone result in 
only five infants, and it is therefore not possible to draw any conclusions about early egg 
specific regulatory responses. It is possible that the intervention induced changes in 
regulatory T-cell function, but for logistic reasons and small sample volumes, it was not 
possible to examine this. 
 
The dynamics of the T cell responses were also of significant interest in this population. It is 
notable that both IL-5 and IL-13 Th2 responses were more pronounced at 4 months and 
waned with age, even in children who had IgE-mediated reactions at 12 months of age on 
challenge. By 12 months, only LYS IL-5 and IL-13 remained significantly elevated in egg 
allergic children. In particular, IL-13 responses to other egg allergens (OVA, OM, CON) 
were comparable to the non-allergic children, despite continued clinical reactivity. Although 
LYS makes up a small percentage of total egg protein (3.5%)[21], up to 35% of egg allergic 
patients have been shown to produce LYS specific-IgE[22]. Thus, LYS seems to be inducing 
more sustained egg-specific inflammatory responses, with higher and more persistent 
production of IL-5 and IL-13 than the other egg proteins. 
 
In conclusion, we have demonstrated that four egg proteins (OVA, OM, CON, LYS) are 
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egg allergy.  Additionally we have shown that these egg-induced immune responses at 4 
months of age predicted egg allergy outcomes at 12 months of age. These results suggest that 
early egg-specific T cell responses may have a long-lasting effect in egg allergy development 
pathways. With egg allergy now one of the most common food allergies affecting children in 
early childhood[3], this study is demonstrating a need for further investigation of the 
influence of egg protein exposures in early life, prior to the introduction of solid foods, on the 
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Figure 1: Flow diagram of trial participants and blood samples collected. 
 
Figure 2: Differences in Th2 cytokine levels for infants randomised into the ‘early egg’ 
intervention group (n=22) who either reacted to the egg powder (n=5, light boxes) or 
tolerated the egg powder (n=17, dark boxes) at 4 months of age.  IL-5 levels (a) and IL-13 (b) 
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Figure 3: IL-5 and IL-13 responses to egg allergens (a) at 4 months of age (n=35, 12 infants 
with subsequent egg allergy at 12 months of age) and (b) at 12 months of age (n=58, 25 
infants with egg-allergy). Categorised based on infants who at 12 months of age had IgE-
mediated egg allergy (light) or infants who tolerated egg (dark). Data shown represents 
median with 10-90th percentile. *(P<0.05).  
 
Figure 4: Changes in IL-5 and IL-13 cytokine responses from 4 months to 12 months of age. 
Cytokine responses in infants with (a) IgE mediated egg allergy and (b) infants who tolerated 
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Table 1: Baseline characteristics of study participants.  
___________________________________________________________________________
_______ 






















Maternal age at birth (years) * 32.7 (5.0) 32.5 (4.7) 
Maternal Caucasian race ^ 52 (76.5%) 68 (79.1%) 
Caesarean-section birth ^ 24 (35.3%) 28 (32.6%) 
1st degree relative history of allergic disease ^ 61 (89.7%) 79 (91.9%) 
Infant male sex ^  46 (67.6%) 57 (66.3%) 
Age of onset of eczema (months) * 1.8 (1.0) 1.8 (1.0) 
Eczema severity (objective SCORAD score) & 12.6 (4.6-25.8) 15.2 (7.2-26.53) 
Use of prescription steroid cream ^ 54 (79.4%) 68 (79.1%) 
Ever breastfed ^ 67 (98.5%) 85 (98.8%) 
Breastfed at randomisation ^ 54 (79.4%) 71 (82.6%) 
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Table 2: Baseline Cytokine Responses at 4 months of age. IL-13 and IL-5 responses (pg/ml) 























* median (Inter Quartile Range) 
 
Cytokine Egg protein 
‘Early Egg’ 
intervention  (n=22) 
‘Delayed Egg’ 
Control (n=18) P value 
IL-13* 
OVA 215.9 (118.0-511.3) 202.4 (109.4-556.1) 0.819 
OM 226.1 (110.5-578.0) 220.3 (54.7-399.0) 0.299 
CON 152.3 (75.6-395.2) 73.1 (28.5-513.1) 0.585 
LYS 198.6 (99.2-748.6) 395.8 (161.2-676.5) 0.528 
IL-5* 
OVA 7.33 (1.4-51.0) 14.3 (1.0-40.6) 0.717 
OM 10.6 (1.3-43.6) 2.42 (1.0-25.5) 0.286 
CON 2.42 (0.9-13.3) 2.42 (1.0-16.2) 0.644 
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Table 3: Cytokine responses at 12 months of age. IL-13 and IL-5 responses (pg/ml) per 
group. 
  




Control (n=25) P value 
IL-13* 
OVA 172.6 (94.3-422.2) 109.7 (58.7-279.0) 0.151 
OM 112.8 (34.9-208.8) 52.6 (21.4-120.1) 0.215 
CON 126.6 (44.5-204.7) 91.3 (40.8-207.3) 0.580 
LYS 98.6 (52.2-342.8) 90.0 (36.6-230.7) 0.733 
IL-5* 
OVA 14.2 (1.0-47.8) 3.4 (1.0-19.4) 0.410 
OM 3.1 (1.0-10.6) 1.0 (1.0-5.24) 0.311 
CON 1.0 (1.0-3.4) 1.0 (1.0-1.2) 0.494 
LYS 2.2 (1.0-24.5) 2.7 (1.0-15.0) 0.985 
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IL-5 responses at  4 months
Egg powder reaction
No reaction
(P=0.025)                                                                    (P=0.025)                       
                                                                                           













IL-13 responses at 4 months
Egg powder reaction
No reaction
(P=0.006)       (P=0.025)       (P=0.039)
                                    
 




























































































 (P=0.004)   (P=0.012)       (P=0.003)       12m egg allergy
12m no allergy















12m no egg allergy
Cytokine responses at 4 months 













(P=0.031)    (P=0.04)    ( P=0.003)   
Cytokine responses at 12 months































































     (P=0.012)
Cyotkine responses over time in egg allergic infants










Cyotkine responses over time in non-allergic infants
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